Priority 23 from the Mesothelioma PSP

UNCERTAINTY: Is there an overall benefit for standard chemotherapy in terms of QALYS (Quality Adjusted Life Years, a measurement that combines survival and quality of life) compared to supportive care alone, for mesothelioma patients? (JLA PSP Priority 23)
Overall ranking 23
JLA question ID 0025/23 
Explanatory note Not available for this PSP
Evidence No systematic reviews or studies identified
Health Research Classification System category Cancer
Extra information provided by this PSP
Original uncertainty examples Treatment needs to be as quick as possible to maximise the patients quality of life within the short time span available ~ To what extent is the Quality of Life issue measured against the effects of chemotherapy for terminal patients? ~ The effects [from chemo] on quality of life were so terrible that - [perhaps] if he might have had a little less time, but better quality, if he had declined chemotherapy ~ Chemo-radiotherapy I believe makes quality of life for patients after treatment poor
Comparison None identified
Submitted by Bereaved x 3 ~ Health Professional
Outcomes to be measured QALYs (Quality Adjusted Life Years)
PSP information
PSP unique ID 0025
PSP name Mesothelioma
Total number of uncertainties identified by this PSP. 53  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 16 December 2014